Newborn screening in Turkey

INFAI and Bruker BioSpin are currently conducting a pilot study to establish NMR spectroscopy in the screening of newborn babies for inborn errors of metabolism. Inborn errors of metabolism affect 1 in 1000 newborns in Central Europe, and an even higher number, 1 in 500, in Turkey. Urine samples of 1500 healthy newborns will be collected on their third day of life in 15 study centers in 8 cities all over Turkey (see map below). The data from healthy newborn babies will be essential as a statistical basis to detect babies suffering from IEM as outliers from the statistical model of "normality".

NMR-Based Screening for Inborn Errors of Metabolism: Initial Results from a Study on Turkish Neonates, JIMD Reports 2014, 16, 101-111

More details can be found in a poster that was presented at the 2011 SSIEM, one poster presented at the 2013 SSIEM, in a flyer or in the product brochure.

 

Diese Seite verwendet Cookies, um Ihnen als Nutzer das bestmögliche Nutzererlebnis zu ermöglichen. Mit der Nutzung unserer Dienste erklären Sie sich mit unserem Einsatz von Cookies einverstanden. Details erfahren Sie hier.